Biodefense - Global Market Outlook (2018-2027)

   |      |      |  

Biodefense - Global Market Outlook (2018-2027)

Global Biodefense market is accounted for $5.47 billion in 2018 and is expected to reach $8.85 billion by 2027 growing at a CAGR of 5.5% during the forecast period. Some of the key factors propelling the market growth are rising investment by the governments in developed countries and technological advancements. However, less penetration in developing and underdeveloped countries is the restraining factor for the growth of the market.

Biodefense constitutes the use of medical measures, to protect individuals against bioterrorism, including interventions, such as drugs and vaccinations. Furthermore, there is an improvement, in terms of research and public health preparations, in order to defend against biological attacks. There is an increasing awareness regarding synthetic biology, mainly for using biological organisms, to reduce the burden of diseases, especially for improving agricultural yields.

By product, vaccines segment is segregated into anthrax, antibiotics, botulism, E-Bola, eye shield, immunization vaccine, nuclear/radiation, smallpox, and zika. Anthrax segment is expected to grow at the significant market share during the forecast period owing to the increased investment on production and stockpiling of anthrax vaccine by government agencies such as the Centre for Disease Control (CDC) and Department of Defense among others.

On the basis of geography, North America is anticipated to hold considerable market share during the forecast period due to increase spending by the governments across the globe to develop and store sufficient vaccines against anthrax and U.S government implementing the number of initiatives that assist them in reinforcing security against biological threats.

Some of the key players in Biodefense Market include Xoma Corporation, Altimmune Inc, Bavarian Nordic, Cleveland BioLabs, Dynavax Technologies Inc, Dynport Vaccine Company LLC (DVC), Elusys Therapeutics, Emergent BioSolutions Inc, Ichor Medical Systems, Nanotherapeutics, Ology Bioservices, PathSensors Inc and Siga Technologies Inc.

Products Covered:
• Vaccines
• Biothreat detection devices

Sales Channels Covered:
• Direct Sales
• In Direct Sales

Applications Covered:
• Military
• Civilian

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain
o Rest of Europe      
• Asia Pacific
o Japan       
o China       
o India       
o Australia        
o New Zealand      
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of     South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary    
      
2 Preface     
 2.1 Abstract    
 2.2 Stake Holders   
 2.3 Research Scope   
 2.4 Research Methodology  
  2.4.1 Data Mining  
  2.4.2 Data Analysis  
  2.4.3 Data Validation  
  2.4.4 Research Approach  
 2.5 Research Sources   
  2.5.1 Primary Research Sources 
  2.5.2 Secondary Research Sources 
  2.5.3 Assumptions  
      
3 Market Trend Analysis   
 3.1 Introduction   
 3.2 Drivers    
 3.3 Restraints   
 3.4 Opportunities    
 3.5 Threats    
 3.6 Product Analysis   
 3.7 Application Analysis  
 3.8 Emerging Markets   
 3.9 Impact of Covid-19 
      
4 Porters Five Force Analysis   
 4.1 Bargaining power of suppliers  
 4.2 Bargaining power of buyers  
 4.3 Threat of substitutes  
 4.4 Threat of new entrants  
 4.5 Competitive rivalry   
      
5 Global Biodefense Market, By Product  
 5.1 Introduction   
 5.2 Vaccines    
  5.2.1 Anthrax   
  5.2.2 Antibiotics  
  5.2.3 Botulism   
  5.2.4 E-Bola   
  5.2.5 Eye Shield  
  5.2.6 Immunization Vaccine 
  5.2.7 Nuclear/Radiation  
  5.2.8 Smallpox   
  5.2.9 Zika   
 5.3 Biothreat detection devices  
  5.3.1 Assays and Reagents 
  5.3.2 Detectors/triggering devices 
  5.3.3 Identifiers  
  5.3.4 Samplers   
      
6 Global Biodefense Market, By Sales Channel 
 6.1 Introduction   
 6.2 Direct Sales   
 6.3 In Direct Sales   
      
7 Global Biodefense Market, By Application 
 7.1 Introduction   
 7.2 Military    
 7.3 Civilian    
      
8 Global Biodefense Market, By Geography 
 8.1 Introduction   
 8.2 North America   
  8.2.1 US   
  8.2.2 Canada   
  8.2.3 Mexico   
 8.3 Europe    
  8.3.1 Germany   
  8.3.2 UK   
  8.3.3 Italy   
  8.3.4 France   
  8.3.5 Spain   
  8.3.6 Rest of Europe  
 8.4 Asia Pacific   
  8.4.1 Japan   
  8.4.2 China   
  8.4.3 India   
  8.4.4 Australia   
  8.4.5 New Zealand  
  8.4.6 South Korea  
  8.4.7 Rest of Asia Pacific  
 8.5 South America   
  8.5.1 Argentina  
  8.5.2 Brazil   
  8.5.3 Chile   
  8.5.4 Rest of South America 
 8.6 Middle East & Africa  
  8.6.1 Saudi Arabia  
  8.6.2 UAE   
  8.6.3 Qatar   
  8.6.4 South Africa  
  8.6.5 Rest of Middle East & Africa 
      
9 Key Developments    
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
 9.2 Acquisitions & Mergers  
 9.3 New Product Launch  
 9.4 Expansions   
 9.5 Other Key Strategies  
      
10 Company Profiling    
 10.1 Xoma Corporation   
 10.2 Altimmune Inc   
 10.3 Bavarian Nordic   
 10.4 Cleveland BioLabs   
 10.5 Dynavax Technologies Inc  
 10.6 Dynport Vaccine Company LLC (DVC) 
 10.7 Elusys Therapeutics   
 10.8 Emergent BioSolutions Inc  
 10.9 Ichor Medical Systems  
 10.10 Nanotherapeutics   
 10.11 Ology Bioservices   
 10.12 PathSensors Inc   
 10.13 Siga Technologies Inc 

 

Biodefense - Global Market Outlook (2018-2027)

List of Tables     
1 Global Biodefense Market Outlook, By Region (2017-2027) ($MN)
2 Global Biodefense Market Outlook, By Vaccines (2017-2027) ($MN)
3 Global Biodefense Market Outlook, By Anthrax (2017-2027) ($MN)
4 Global Biodefense Market Outlook, By Antibiotics (2017-2027) ($MN)
5 Global Biodefense Market Outlook, By Botulism (2017-2027) ($MN)
6 Global Biodefense Market Outlook, By E-Bola (2017-2027) ($MN)
7 Global Biodefense Market Outlook, By Eye Shield (2017-2027) ($MN)
8 Global Biodefense Market Outlook, By Immunization Vaccine (2017-2027) ($MN)
9 Global Biodefense Market Outlook, By Nuclear/Radiation (2017-2027) ($MN)
10 Global Biodefense Market Outlook, By Smallpox (2017-2027) ($MN)
11 Global Biodefense Market Outlook, By Zika (2017-2027) ($MN)
12 Global Biodefense Market Outlook, By Biothreat detection devices (2017-2027) ($MN)
13 Global Biodefense Market Outlook, By Assays and Reagents (2017-2027) ($MN)
14 Global Biodefense Market Outlook, By Detectors/triggering devices (2017-2027) ($MN)
15 Global Biodefense Market Outlook, By Identifiers (2017-2027) ($MN)
16 Global Biodefense Market Outlook, By Samplers (2017-2027) ($MN)
17 Global Biodefense Market Outlook, By Sales Channel (2017-2027) ($MN)
18 Global Biodefense Market Outlook, By Direct Sales (2017-2027) ($MN)
19 Global Biodefense Market Outlook, By In Direct Sales (2017-2027) ($MN)
20 Global Biodefense Market Outlook, By Application (2017-2027) ($MN)
21 Global Biodefense Market Outlook, By Military (2017-2027) ($MN)
22 Global Biodefense Market Outlook, By Civilian (2017-2027) ($MN)
23 North America Biodefense Market Outlook, By Country (2017-2027) ($MN)
24 North America Biodefense Market Outlook, By Vaccines (2017-2027) ($MN)
25 North America Biodefense Market Outlook, By Anthrax (2017-2027) ($MN)
26 North America Biodefense Market Outlook, By Antibiotics (2017-2027) ($MN)
27 North America Biodefense Market Outlook, By Botulism (2017-2027) ($MN)
28 North America Biodefense Market Outlook, By E-Bola (2017-2027) ($MN)
29 North America Biodefense Market Outlook, By Eye Shield (2017-2027) ($MN)
30 North America Biodefense Market Outlook, By Immunization Vaccine (2017-2027) ($MN)
31 North America Biodefense Market Outlook, By Nuclear/Radiation (2017-2027) ($MN)
32 North America Biodefense Market Outlook, By Smallpox (2017-2027) ($MN)
33 North America Biodefense Market Outlook, By Zika (2017-2027) ($MN)
34 North America Biodefense Market Outlook, By Biothreat detection devices (2017-2027) ($MN)
35 North America Biodefense Market Outlook, By Assays and Reagents (2017-2027) ($MN)
36 North America Biodefense Market Outlook, By Detectors/triggering devices (2017-2027) ($MN)
37 North America Biodefense Market Outlook, By Identifiers (2017-2027) ($MN)
38 North America Biodefense Market Outlook, By Samplers (2017-2027) ($MN)
39 North America Biodefense Market Outlook, By Sales Channel (2017-2027) ($MN)
40 North America Biodefense Market Outlook, By Direct Sales (2017-2027) ($MN)
41 North America Biodefense Market Outlook, By In Direct Sales (2017-2027) ($MN)
42 North America Biodefense Market Outlook, By Application (2017-2027) ($MN)
43 North America Biodefense Market Outlook, By Military (2017-2027) ($MN)
44 North America Biodefense Market Outlook, By Civilian (2017-2027) ($MN)
45 Europe Biodefense Market Outlook, By Country (2017-2027) ($MN)
46 Europe Biodefense Market Outlook, By Vaccines (2017-2027) ($MN)
47 Europe Biodefense Market Outlook, By Anthrax (2017-2027) ($MN)
48 Europe Biodefense Market Outlook, By Antibiotics (2017-2027) ($MN)
49 Europe Biodefense Market Outlook, By Botulism (2017-2027) ($MN)
50 Europe Biodefense Market Outlook, By E-Bola (2017-2027) ($MN)
51 Europe Biodefense Market Outlook, By Eye Shield (2017-2027) ($MN)
52 Europe Biodefense Market Outlook, By Immunization Vaccine (2017-2027) ($MN)
53 Europe Biodefense Market Outlook, By Nuclear/Radiation (2017-2027) ($MN)
54 Europe Biodefense Market Outlook, By Smallpox (2017-2027) ($MN)
55 Europe Biodefense Market Outlook, By Zika (2017-2027) ($MN)
56 Europe Biodefense Market Outlook, By Biothreat detection devices (2017-2027) ($MN)
57 Europe Biodefense Market Outlook, By Assays and Reagents (2017-2027) ($MN)
58 Europe Biodefense Market Outlook, By Detectors/triggering devices (2017-2027) ($MN)
59 Europe Biodefense Market Outlook, By Identifiers (2017-2027) ($MN)
60 Europe Biodefense Market Outlook, By Samplers (2017-2027) ($MN)
61 Europe Biodefense Market Outlook, By Sales Channel (2017-2027) ($MN)
62 Europe Biodefense Market Outlook, By Direct Sales (2017-2027) ($MN)
63 Europe Biodefense Market Outlook, By In Direct Sales (2017-2027) ($MN)
64 Europe Biodefense Market Outlook, By Application (2017-2027) ($MN)
65 Europe Biodefense Market Outlook, By Military (2017-2027) ($MN)
66 Europe Biodefense Market Outlook, By Civilian (2017-2027) ($MN)
67 Asia Pacific Biodefense Market Outlook, By Country (2017-2027) ($MN)
68 Asia Pacific Biodefense Market Outlook, By Vaccines (2017-2027) ($MN)
69 Asia Pacific Biodefense Market Outlook, By Anthrax (2017-2027) ($MN)
70 Asia Pacific Biodefense Market Outlook, By Antibiotics (2017-2027) ($MN)
71 Asia Pacific Biodefense Market Outlook, By Botulism (2017-2027) ($MN)
72 Asia Pacific Biodefense Market Outlook, By E-Bola (2017-2027) ($MN)
73 Asia Pacific Biodefense Market Outlook, By Eye Shield (2017-2027) ($MN)
74 Asia Pacific Biodefense Market Outlook, By Immunization Vaccine (2017-2027) ($MN)
75 Asia Pacific Biodefense Market Outlook, By Nuclear/Radiation (2017-2027) ($MN)
76 Asia Pacific Biodefense Market Outlook, By Smallpox (2017-2027) ($MN)
77 Asia Pacific Biodefense Market Outlook, By Zika (2017-2027) ($MN)
78 Asia Pacific Biodefense Market Outlook, By Biothreat detection devices (2017-2027) ($MN)
79 Asia Pacific Biodefense Market Outlook, By Assays and Reagents (2017-2027) ($MN)
80 Asia Pacific Biodefense Market Outlook, By Detectors/triggering devices (2017-2027) ($MN)
81 Asia Pacific Biodefense Market Outlook, By Identifiers (2017-2027) ($MN)
82 Asia Pacific Biodefense Market Outlook, By Samplers (2017-2027) ($MN)
83 Asia Pacific Biodefense Market Outlook, By Sales Channel (2017-2027) ($MN)
84 Asia Pacific Biodefense Market Outlook, By Direct Sales (2017-2027) ($MN)
85 Asia Pacific Biodefense Market Outlook, By In Direct Sales (2017-2027) ($MN)
86 Asia Pacific Biodefense Market Outlook, By Application (2017-2027) ($MN)
87 Asia Pacific Biodefense Market Outlook, By Military (2017-2027) ($MN)
88 Asia Pacific Biodefense Market Outlook, By Civilian (2017-2027) ($MN)
89 South America Biodefense Market Outlook, By Country (2017-2027) ($MN)
90 South America Biodefense Market Outlook, By Vaccines (2017-2027) ($MN)
91 South America Biodefense Market Outlook, By Anthrax (2017-2027) ($MN)
92 South America Biodefense Market Outlook, By Antibiotics (2017-2027) ($MN)
93 South America Biodefense Market Outlook, By Botulism (2017-2027) ($MN)
94 South America Biodefense Market Outlook, By E-Bola (2017-2027) ($MN)
95 South America Biodefense Market Outlook, By Eye Shield (2017-2027) ($MN)
96 South America Biodefense Market Outlook, By Immunization Vaccine (2017-2027) ($MN)
97 South America Biodefense Market Outlook, By Nuclear/Radiation (2017-2027) ($MN)
98 South America Biodefense Market Outlook, By Smallpox (2017-2027) ($MN)
99 South America Biodefense Market Outlook, By Zika (2017-2027) ($MN)
100 South America Biodefense Market Outlook, By Biothreat detection devices (2017-2027) ($MN)
101 South America Biodefense Market Outlook, By Assays and Reagents (2017-2027) ($MN)
102 South America Biodefense Market Outlook, By Detectors/triggering devices (2017-2027) ($MN)
103 South America Biodefense Market Outlook, By Identifiers (2017-2027) ($MN)
104 South America Biodefense Market Outlook, By Samplers (2017-2027) ($MN)
105 South America Biodefense Market Outlook, By Sales Channel (2017-2027) ($MN)
106 South America Biodefense Market Outlook, By Direct Sales (2017-2027) ($MN)
107 South America Biodefense Market Outlook, By In Direct Sales (2017-2027) ($MN)
108 South America Biodefense Market Outlook, By Application (2017-2027) ($MN)
109 South America Biodefense Market Outlook, By Military (2017-2027) ($MN)
110 South America Biodefense Market Outlook, By Civilian (2017-2027) ($MN)
111 Middle East & Africa Biodefense Market Outlook, By Country (2017-2027) ($MN)
112 Middle East & Africa Biodefense Market Outlook, By Vaccines (2017-2027) ($MN)
113 Middle East & Africa Biodefense Market Outlook, By Anthrax (2017-2027) ($MN)
114 Middle East & Africa Biodefense Market Outlook, By Antibiotics (2017-2027) ($MN)
115 Middle East & Africa Biodefense Market Outlook, By Botulism (2017-2027) ($MN)
116 Middle East & Africa Biodefense Market Outlook, By E-Bola (2017-2027) ($MN)
117 Middle East & Africa Biodefense Market Outlook, By Eye Shield (2017-2027) ($MN)
118 Middle East & Africa Biodefense Market Outlook, By Immunization Vaccine (2017-2027) ($MN)
119 Middle East & Africa Biodefense Market Outlook, By Nuclear/Radiation (2017-2027) ($MN)
120 Middle East & Africa Biodefense Market Outlook, By Smallpox (2017-2027) ($MN)
121 Middle East & Africa Biodefense Market Outlook, By Zika (2017-2027) ($MN)
122 Middle East & Africa Biodefense Market Outlook, By Biothreat detection devices (2017-2027) ($MN)
123 Middle East & Africa Biodefense Market Outlook, By Assays and Reagents (2017-2027) ($MN)
124 Middle East & Africa Biodefense Market Outlook, By Detectors/triggering devices (2017-2027) ($MN)
125 Middle East & Africa Biodefense Market Outlook, By Identifiers (2017-2027) ($MN)
126 Middle East & Africa Biodefense Market Outlook, By Samplers (2017-2027) ($MN)
127 Middle East & Africa Biodefense Market Outlook, By Sales Channel (2017-2027) ($MN)
128 Middle East & Africa Biodefense Market Outlook, By Direct Sales (2017-2027) ($MN)
129 Middle East & Africa Biodefense Market Outlook, By In Direct Sales (2017-2027) ($MN)
130 Middle East & Africa Biodefense Market Outlook, By Application (2017-2027) ($MN)
131 Middle East & Africa Biodefense Market Outlook, By Military (2017-2027) ($MN)
132 Middle East & Africa Biodefense Market Outlook, By Civilian (2017-2027) ($MN)

 

.